Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lu AE 58054. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN104418793A enables cost reduction in API manufacturing via efficient route. High-purity Alzheimer's drug intermediate available for commercial scale-up.
Novel patent CN104418793B reveals a cost-efficient route for Lu-AE-58054 using m-cresol, offering significant supply chain advantages for Alzheimer's drug manufacturers.